ARK Invest is increasing its investment in biotechnology.

ARK Invest Increases Investment in Biotechnology

ARK Invest, led by Cathie Wood, has noticeably increased its investments in the fields of biotechnology, genomics, and deep technology in recent times. The fund is following this strategy by reducing its investments in diagnostics, software, and communications ahead of significant data releases expected in the coming quarters.

Investment Moves and New Positions

ARK Invest raised its total position in the artificial intelligence-driven drug discovery platform Recursion Pharmaceuticals (RXRX) to $127 million by purchasing 1.04 million shares. Additionally, by acquiring 211,000 shares of CRISPR Therapeutics (CRSP), the total investment in this company has increased to $472 million. These investments stand out as a reflection of the growth potential in the gene editing field.

Investments in Blockchain and Crypto Assets

ARK Invest solidified its confidence in innovative blockchain-based payment systems by purchasing approximately 394,000 shares of Circle (CRCL). With this move, the total position value in CRCL has surpassed $262 million. Furthermore, the interest in the crypto ecosystem was clearly highlighted by acquiring a total of 1.75 million shares in the areas of crypto mining with Bitmine Immersion Technologies (BMNR) and digital asset exchange provider Bullish (BLSH).

Sales in the Semiconductor and Diagnostics Sectors

In the semiconductor sector, the purchase of 93,000 shares of Nvidia (NVDA) stands out. However, there has been a general reduction in positions within the sector, with significant sales occurring in companies such as Illumina (ILMN), Robinhood (HOOD), Coinbase (COIN), and Shopify (SHOP), which is part of ARK Invest's strategy to focus on biotechnology and deep technology.

Market Strategy and Future Expectations

As part of its investment strategies, sales were made in the diagnostics sector, including 1.16 million shares of Exact Sciences (EXAS), 41,000 shares of Natera (NTRA), and 670,000 shares of GitLab (GTLB). Additionally, a similar reduction was observed in the communications and semiconductor sectors.